Sentinelle Medical Receives Frost & Sullivan Excellence in Technology Award

TORONTO, March 24 /PRNewswire/ - Sentinelle Medical Inc., a leading
manufacturer of breast MRI coils and software has been honoured with Frost &
Sullivan's 2009 North American Excellence in Technology Award (within the MRI
Scanners Market). Sentinelle receives this Award in recognition of the
tremendous success of its Vanguard 1.5T breast imaging coils product line in
2008, highlighted by a number of exclusive distribution agreements secured
with leading MRI manufacturers.
Frost & Sullivan's Best Practices Awards recognize companies in a variety of
regional and global markets for demonstrating outstanding achievement and
superior performance in areas such as leadership, technological innovation,
customer service, and strategic product development. Industry analysts compare
market participants and measure performance through in-depth interviews,
analysis, and extensive secondary research in order to identify best
practices.
"Breast cancer will impact 200,000 women in North America this year.
Sentinelle was founded with the goal of providing the most powerful tools to
support radiologists, technologists, and oncologists in their efforts for
earlier detection and improved treatment of cancer. Our approach has been to
work with leading clinicians to understand and address the challenges they
face in new and innovative ways," said Cameron Piron, Sentinelle's President
and CEO. "This past year has been extremely rewarding for the Sentinelle team.
Not only have we been able to partner with MRI market leaders like GE, Siemens
and Toshiba, but we are being recognized for our innovations with this
prestigious Award."
"Sentinelle's Vanguard technologies significantly improve the diagnostic
capabilities and patient comfort for Breast MRI," said Frost & Sullivan
Industry Analyst Travis Chong. "Sentinelle has quickly gained recognition as a
technology leader with its advanced ergonomic Vanguard design and adjustable
visco-elastic padding that enables clinicians to achieve greater image
resolution and improved patient management. With clear improvements to both
the form and function of an MRI auxiliary table, it's no wonder why the
company has achieved tremendous growth within the emerging Breast MRI market."
The Frost & Sullivan Excellence in Technology Award is bestowed upon a company
that has pioneered the development and introduction of an innovative
technology into the market. The award recognizes a company's successful
technology development that is expected to bring significant contributions to
the industry in terms of adoption, change, and competitive posture. It also
recognizes the company's overall technical excellence and its commitment
toward technology innovation.

About Sentinelle Medical Inc.

Sentinelle Medical is dedicated to improving patient care with early detection
and accurate intervention. The company researches, develops, manufactures,
sells and supports leading edge Magnetic Resonance (MR) technologies. The
ground breaking Sentinelle Vanguard Breast MR Auxiliary Table(R) provides
excellent quality MR images, complete and open access for intervention and
award winning design that optimizes patient comfort and workflow. Sentinelle
products are used in leading breast cancer sites throughout North America
including Dartmouth-Hitchcock Medical Centre, H. Lee Moffitt Cancer Center and
Research Institute (University of South Florida), Scripps Memorial Hospital,
Sunnybrook Health Sciences Centre and University Health Network. Sentinelle
Medical is a privately owned Canadian company.
For more information, visit www.sentinellemedical.com.

SOURCE Sentinelle Medical Inc.

Media Contact: Wendy Low, Sentinelle Medical Inc., (416) 482-3823,
wendy.low@sentinellemedical.com